MRNA

Moderna

$50.96

-0.32 (-0.62%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 13.04.2026
$45.15
(-11.4%)
Strong Buy: 2
Buy: 2
Hold: 17
Sell: 1
Strong Sell: 2
Description:
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
325 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
Fiscal year end:
December
Market capitalization:
$20.2 Billion
EBITDA:
-$2.86 Billion
PERatio:
0.0
EPS:
-7.26
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.336

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 8 years:
+173%
How much will you get:
$2,731
Prices dates:
07-12-2018: $18.60 and 31-03-2026: $50.80